首页> 外文期刊>Journal of the Chinese Medical Association: JCMA >Role of endoscopic papillary balloon dilation in patients with recurrent bile duct stones after endoscopic sphincterotomy
【24h】

Role of endoscopic papillary balloon dilation in patients with recurrent bile duct stones after endoscopic sphincterotomy

机译:内镜下乳头球囊扩张术在内镜括约肌切开术后复发性胆管结石患者中的作用

获取原文
           

摘要

Background: Endoscopic sphincterotomy (ES) is an established treatment for patients with choledocholithiasis or common bile duct stones (CBDS), but further management of patients after ES with recurrent CBDS remains controversial. Endoscopic papillary large balloon dilation (EPLBD) has been used safely and effectively for stone removal in patients after ES with recurrent CBDS. The aim of this study was to evaluate the clinical efficacy of EPLBD in patients after complete ES with recurrent CBDS. Methods: Records of 891 patients with CBDS after complete ES from January 1991 to December 2008 were reviewed. Of 133 patients with recurrent CBDS, 122 had complete endoscopic bile duct clearance. Twenty-three patients (Group 1) underwent EPLBD and 99 (Group 2) underwent stone extraction without dilatation. Basic demographics and endoscopic findings at the first recurrence were recorded and analyzed. The primary end point was the second CBDS recurrence. Results: No statistical differences were observed between the two groups, except for larger CBDS size in Group 1. The bile duct clearance rate was 96% in Group 1 and 91% in Group 2. No complications such as pancreatitis, perforation, and bleeding were noted in Group 1, and one patient in Group 2 suffered from bleeding after stone extraction. The rate of second recurrent CBDS after endoscopic clearance for the first recurrent CBDS was 17% in Group 1 and 60% in Group 2 (p?
机译:背景:内镜下括约肌切开术(ES)是胆总管结石症或胆总管结石(CBDS)患者的既定治疗方法,但ES C复发CBDS后患者的进一步治疗仍存在争议。内镜下乳头状大球囊扩张术(EPLBD)已被安全有效地用于复发性CBDS的ES患者的结石清除。这项研究的目的是评估完全复发性CBDS合并ES患者后EPLBD的临床疗效。方法:回顾性分析了1991年1月至2008年12月完成891例ES的CBDS患者的记录。在133例复发性CBDS患者中,有122例具有完整的内镜下胆管清除率。 23例患者(第1组)接受了EPLBD,99例患者(第2组)接受了无扩张的结石摘除术。记录并分析首次复发时的基本人口统计学和内窥镜检查结果。主要终点是第二次CBDS复发。结果:两组之间无统计学差异,除了第1组中的CBDS较大。第1组的胆管清除率为96%,第2组的胆管清除率为91%。未出现胰腺炎,穿孔和出血等并发症在第1组中注意到,第2组中有1名患者在取出结石后出血。内镜清除后第一组复发性CBDS的第二次复发性CBDS的发生率在第1组为17%,在第2组为60%(p <0.001)。第二次复发有两个独立的因素,包括肝硬化(比值4.734,p <= 0.023)和直接取石而无较大乳头扩张(比值6.050,p = 0.003)。结论:EPLBD是一种安全有效的内镜治疗ES术后复发性CBDS的方法。它还可以促进对CBDS的彻底清除并防止CBDS再次复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号